Vytelle Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
106
- Latest Deal Type
-
M&A
Vytelle General Information
Description
Operator of a biotechnology platform intended to assist in advancing bovine, deer, and buffalo genetics by redefining reproduction. The company's integrated platform leverages reproductive technology through industry specialists and veterinarian licensees to develop embryos using a proprietary culture system with no fetal calf serum, resulting in freezable embryos, enabling commercial producers to get generations of genetic gains that are sustainable for animals.
Contact Information
Website
www.vytelle.com(Operating Subsidiary)
Corporate Office
- 8789 Penrose Lan
- Suite 250
- Lenexa, KS 66219
- United States
Corporate Office
- 8789 Penrose Lan
- Suite 250
- Lenexa, KS 66219
- United States
Vytelle Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 26-May-2026 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 03-Apr-2023 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 21-Sep-2021 | $15.3M | $15.3M | Completed | Generating Revenue |
Vytelle Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Vytelle Patents
Vytelle Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024308993-A1 | Genotyping of cell-free dna from embryo culture media | Pending | 27-Jun-2023 | ||
| US-20250029679-A1 | Genotyping of cell-free dna from embryo culture media | Pending | 27-Jun-2023 | ||
| WO-2025006702-A1 | Genotyping of cell-free dna from embryo culture media | Inactive | 27-Jun-2023 | ||
| AU-2024253144-A1 | Microbiome treatments for animal fertility | Pending | 04-Apr-2023 | ||
| US-20240366690-A1 | Microbiome treatments for animal fertility | Pending | 04-Apr-2023 | A61K35/74 |
Vytelle Signals
Vytelle Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ag-tech VC | Venture Capital | Minority | ||
| Forage Capital Partners | PE/Buyout | Minority | ||
| Fulcrum Global Capital | Venture Capital | Minority | ||
| Grosvenor Food & AgTech | Impact Investing | Minority | ||
| KCRise Fund | Venture Capital | Minority |
Vytelle Acquisitions (1)
Vytelle’s most recent deal was a Merger/Acquisition with GrowSafe Systems. The deal was made on 13-Aug-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GrowSafe Systems | 13-Aug-2020 | Merger/Acquisition | Electronic Equipment and Instruments |
Vytelle FAQs
-
When was Vytelle founded?
Vytelle was founded in 2015.
-
Where is Vytelle headquartered?
Vytelle is headquartered in Lenexa, KS.
-
What is the size of Vytelle?
Vytelle has 106 total employees.
-
What industry is Vytelle in?
Vytelle’s primary industry is Other Agriculture.
-
Is Vytelle a private or public company?
Vytelle is a Private company.
-
What is Vytelle’s current revenue?
The current revenue for Vytelle is .
-
How much funding has Vytelle raised over time?
Vytelle has raised $35.3M.
-
Who are Vytelle’s investors?
Ag-tech VC, Forage Capital Partners, Fulcrum Global Capital, Grosvenor Food & AgTech, and KCRise Fund are 5 of 9 investors who have invested in Vytelle.
-
When was Vytelle acquired?
Vytelle was acquired on 26-May-2026.
-
Who acquired Vytelle?
Vytelle was acquired by Trans Ova Genetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process